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ABSTRACT Evidence for a possible protective effect of maternal dietary antioxidant intake during
pregnancy on childhood asthma and other atopic outcomes is conflicting, and associations with childhood
lung function have been little studied.
In the Avon Longitudinal Study of Parents and Children, we analysed associations between maternal
intake of fruits, vegetables, vitamins C and E, carotene, zinc, and selenium in pregnancy and current
doctor-diagnosed asthma, atopy and lung function in 8915 children at age 7–9 years. Potential
modification of associations by maternal smoking and common maternal antioxidant gene polymorphisms
was explored to strengthen causal inference.
After controlling for confounders, positive associations were observed between maternal intake of zinc
and childhood forced expiratory volume in 1 s and forced vital capacity (difference in age-, height- and
sex-adjusted SD units per quartile increase in maternal dietary zinc intake β 0.05 (95% CI 0.01–0.08);
ptrend=0.01 and 0.05 (95% CI 0.02–0.09); ptrend=0.005, respectively). Weak evidence was found for an
interaction between maternal zinc intake and maternal glutathione S-transferase GSTM1 genotype on
childhood forced vital capacity (pinteraction=0.05); association among the GSTM1 null group β 0.11 (95%
CI 0.05–0.17); ptrend=0.001.
Our results suggest that a higher maternal intake of zinc during pregnancy may be associated with
better lung function in the offspring.
This article has supplementary material available from erj.ersjournals.com
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Introduction
A declining dietary intake of antioxidants has been proposed as a possible explanation for the large
increase in the prevalence of asthma and atopy seen in the West in recent decades [1], and this has led to
interest in the role of maternal antioxidant dietary intake in pregnancy in the aetiology of childhood
asthma and atopic diseases. Although some studies have suggested a possible protective effect of maternal
intake of vitamin E, zinc, fruits and vegetables during pregnancy [2–4], the evidence overall is conflicting.
A recent meta-analysis concluded that, while there is some evidence for a protective effect of maternal
intake of zinc and vitamin E on childhood wheeze, evidence regarding asthma and other atopic outcomes
is inconclusive [5]. Evidence regarding childhood lung function is limited to one study [2].
A concern with all observational studies, and particularly in nutritional epidemiology, is that findings may
be confounded [6]. One way to strengthen causal inference is to demonstrate biologically plausible
interactions. Researchers have hypothesised that a diet low in antioxidants may increase susceptibility to
oxidant injury and airway inflammation [7]. Maternal smoking during pregnancy has been associated with
adverse respiratory outcomes in children [8, 9] and in the Avon Longitudinal Study of Parents and
Children (ALSPAC), maternal smoking during pregnancy was associated with reduced mid-expiratory
flows in childhood [10]. A recent randomised clinical trial suggested that vitamin C supplementation in
pregnant, smoking females may reduce the deleterious effect of maternal smoking on infant pulmonary
function [11]. However, to the best of our knowledge, no observational study has investigated potential
interactions between maternal dietary antioxidant intake and maternal smoking during pregnancy on
respiratory and atopic outcomes in later childhood. Similarly, interactions between maternal diet and
common antioxidant gene polymorphisms have not been explored, although a few studies conducted in
children have investigated possible interactions between common glutathione S-transferase (GST) gene
polymorphisms and antioxidant intake on atopic and respiratory outcomes [12–14].
The aim of this study was to investigate the associations between maternal intake of dietary antioxidants in
pregnancy and childhood respiratory and atopic outcomes (including lung function), and to explore
whether these associations were modified by maternal smoking during pregnancy and common maternal
antioxidant gene polymorphisms, which could potentially strengthen causal inference.
Methods
Participants
The ALSPAC is a population-based birth cohort that recruited 14541 predominantly White pregnant
females resident in Avon, UK with expected dates of delivery from April 1, 1991 to December 31, 1992.
These pregnancies resulted in 13613 singletons who were alive at 1 year of age. The cohort has been
followed since birth with annual questionnaires and, since age 7 years, with objective measures in annual
research clinics. The study protocol has been described previously [15, 16] and further information can be
found at: http://www.alspac.bris.ac.uk, which contains details of all the data that are available (http://www.
bris.ac.uk/alspac/researchers/data-access/data-dictionary/). Ethics approval was obtained from the ALSPAC
Ethics and Law Committee (IRB 00003312) and the Local NHS Research Ethics Committees
Outcome assessment
Children were defined as having current doctor-diagnosed asthma at 7.5 years (primary outcome) if
mothers responded positively to the question “Has a doctor ever actually said that your study child has
asthma?” and positively to one or both of the questions “Has your child had any of the following in the
past 12 months: wheezing with whistling; asthma?”. Parental reports of a doctor’s diagnosis of asthma
agree well with a general practitioner-recorded diagnosis in ALSPAC [17]. Atopy at 7 years was defined as
a positive reaction (maximum diameter of any detectable weal) to Dermatophagoides pteronyssinus, cat or
grass (after subtracting positive saline reactions from histamine and allergen weals, and excluding children
unreactive to 1% histamine). Lung function was measured by spirometry (Vitalograph 2120; Vitalograph¸
Maids Moreton, UK) at age 8.5 years after withholding short-acting bronchodilators for at least 6 h and
long-acting bronchodilators and theophyllines for at least 24 h. The best of three reproducible flow–
volume curves was used to measure forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC)
and maximal mid-expiratory flow (i.e. forced expiratory flow at 25–75% of FVC (FEF25–75)). Lung
function measurements were transformed to age-, height- and sex-adjusted SD units [18]. The tests adhered
to American Thoracic Society (ATS) criteria for standardisation and reproducibility of flow–volume
measurement [19], with the exception of ATS recommendations for duration of expiration, since many
young children cannot sustain exhalation for 6 s to establish FVC [20]. We therefore used no volume
change over >1 s to define the plateau phase of the flow–volume curve as the end-of-test criterion in those
unable to blow >6 s. Lung function at 15 years was also considered as a secondary outcome of interest in
post hoc analyses (see Statistical analyses section).
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Exposures of interest
Data on maternal diet in pregnancy were collected by a food frequency questionnaire (FFQ) sent out at
32 weeks gestation to mothers, covering all the main foods consumed in Britain [21]. The questionnaire
included questions about the weekly frequency of consumption of 43 food groups and food items, with the
possibility for respondents to tick one of the following options: never or rarely, once in 2 weeks, 1–3 times
a week, 4–7 times a week, or more than once a day. One question on the weekly frequency of fresh fruit
consumption and six questions on the weekly frequency of vegetables (peas, sweetcorn, broad beans;
cabbage, brussels sprouts, kale and other green leafy vegetables; other green vegetables; carrots; other root
vegetables; salad) were used to estimate weekly intake of fruits and vegetables, respectively, using standard
portions [22]. The FFQ was used to estimate daily nutrient intakes for each female, by multiplying the
daily frequency of consumption of a food by the nutrient content [23] of a standard portion [22] of that
food and summing this for all the foods consumed. Daily intakes of vitamins C and E, zinc, selenium, and
carotene were estimated in this way. To ensure consistency, all dietary exposure variables were categorised
in quartiles. A maternal dietary antioxidant score was derived for each mother by adding the intake
quartile for each of the five antioxidant nutrients, thus ranging from 5 to 20. Information on the child’s
intake of antioxidants at 3 years, and maternal and paternal antioxidant intake at 4 years post-partum, was
collected using a similar FFQ.
Maternal smoking during pregnancy
Maternal smoking habits during the 3 months before pregnancy and at several time-points during
pregnancy were recorded using self-reported questionnaires on an ordinal categorical scale (never, passive
smoking only, 1–9 cigarettes per day, 10–19 cigarettes per day or ⩾20 cigarettes per day). The highest
category reported at any time during pre-pregnancy or pregnancy was used in the analysis.
Genotypes of interest
Maternal DNA was a mixture of samples extracted from blood collected during pregnancy and from
lymphoblastoid cell lines. The majority of the children’s DNA samples were extracted from cord blood or
venous blood collected at age 7 years, with a small number extracted from venous blood collected at
43–61 months. The GSTT1 and GSTM1 gene deletion genotyping was performed using a real-time PCR
method described previously [24]. Two single nucleotide polymorphisms (SNPs) were typed in mothers
and children by LGC Genomics (formerly KBiosciences, Hoddesdon, UK), using a competitive
allele-specific PCR system (KASPar): a SNP in GSTP1 (G313A, Ile105Val, rs1695) and a SNP in GPX4
(glutathione peroxidase 4; rs713041, at position 718). The GST gene polymorphisms are common and we
have previously investigated their role (and interactions) in childhood asthma in ALSPAC [25, 26]. We
have also reported interactions between pre-natal selenium status and childhood GPX4 genotype on
childhood asthma (glutathione peroxidase 4 is a selenium-dependent enzyme) [27].
Potential confounders
We selected potential confounding factors that are known (from existing literature) to be associated with
one or more of the outcomes of interest [28]. These included maternal age at delivery, sex of child,
multiple pregnancy, season of birth, maternal history of atopic diseases (hay fever, asthma, eczema,
allergies, or attacks of wheezing with whistling on the chest or attacks of breathlessness in the past
2 years), parity, highest educational qualification, housing tenure, financial difficulties, ethnicity,
breastfeeding duration and maternal factors during pregnancy (smoking status, anxiety score (Crown–
Crisp Experiential Index) [29], paracetamol use, antibiotic use, infections (urinary infection, influenza,
rubella, thrush, genital herpes, other), supplement use and total energy intake (kJ·day−1)).
Statistical analyses
Logistic regression and linear regression were used to analyse associations between dietary exposure variables
and binary and continuous outcomes, respectively. Dietary exposure variables were analysed in quartiles, first
as a categorical variable using the lowest quartile as reference to allow for a nonlinear pattern of association
and second as a continuous variable to test for linear trend (i.e. per increasing quartile effect). For all
regression analyses, two stages of adjustment were used. In Model 1, we adjusted for total energy intake only.
In Model 2, we adjusted additionally for all potential confounders listed previously.
Sensitivity analyses
When evidence for associations persisted after adjustment for potential confounders, we conducted a
number of additional analyses: 1) additional adjustment for potential mediators (i.e. gestational age at
delivery [30, 31], birthweight [32, 33], maternal pre-pregnancy body mass index (BMI) and weight gain
during pregnancy [34–36], and child’s BMI at age 7 years [37, 38]; see supplementary figure S1 for
directed acyclic graph); 2) additional adjustment for maternal dietary intake of total polyunsaturated fatty
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acids [5]; 3) mutual adjustment for maternal dietary intake of antioxidants that were found to be associated
with the same childhood outcome; 4) exclusion of mothers taking supplements in pregnancy (vitamins/
zinc); and 5) exclusion of mothers with implausible energy intakes (<2500 or >25000 kJ·day−1 [39]).
Further investigation of confounding
We also used two approaches to further investigate potential confounding of associations with pre-natal
exposures: 1) we controlled additionally for child’s intake of the same exposure at 3 years of age and 2) we
used a parental comparison approach to investigate potential unmeasured confounding by genetic or
shared environmental or lifestyle factors (further details in supplementary material) [40, 41].
To correct for potential loss to follow-up bias, we used inverse probability weighting and assigned to each
female a weight that is the inverse of the probability of her selection for given values of covariates (further
details in supplementary material) [42].
Exploration of interactions
To explore potential modification of dietary associations by maternal smoking we stratified by maternal
smoking history (dichotomised) and tested for interaction. Maternal smoking during pregnancy has been
found to be associated with reduced childhood FEF25–75 in ALSPAC [10]. To explore potential
modification of this association by maternal dietary antioxidant exposures, we stratified by antioxidant
intake (above versus below median) and tested for interaction. Distributions of allele frequencies for each
polymorphism in mothers and children were formally tested for deviation from Hardy–Weinberg
equilibrium using a likelihood ratio test. To investigate whether associations between dietary exposures and
childhood outcomes were modified by maternal antioxidant genotype, we stratified by maternal GSTM1
and GSTT1 null genotypes, and by GSTP1 genotype. We also stratified the associations between maternal
dietary selenium intake and outcomes by maternal GPX4 genotype (since glutathione peroxidase 4 is a
selenium-dependent enzyme). All statistical analyses were carried out using Stata version 12.1 (StataCorp,
College Station, TX, USA).
Results
Of the 13972 singletons and twins alive at 1 year of age, information on maternal diet during pregnancy
was available for 12078, of whom there was information on at least one of the outcomes of interest for
8915 children (supplementary figure S2). Characteristics of the 8915 mother–child pairs who were
included in the analyses and those of the 3163 mother–child pairs with information on maternal diet who
were excluded because of incomplete outcome data are compared in table 1.
After controlling for energy intake only, maternal intakes of fruits and vitamin C during pregnancy were
negatively associated with childhood asthma. However, these associations attenuated towards the null after
further adjustment for potential confounders (table 2). No other association was found between other
dietary antioxidant exposures and childhood asthma or atopy (table 2). After controlling for energy intake
and all other potential confounders, there was weak evidence for a positive association between maternal
intake of vegetables and childhood FEV1 and FEF25–75 (table 3). Positive associations were observed
between maternal intake of zinc and childhood FEV1 and FVC, with evidence of a dose–response
relationship. There was weaker evidence for positive associations between maternal carotene intake and
childhood FEV1 and FVC, and between maternal selenium intake and childhood FVC (table 3). Positive
associations were observed between the maternal antioxidant score and childhood FEV1 and FVC, with
evidence of a dose–response relationship (table 3). If zinc intake was omitted from the antioxidant score,
the latter was no longer significantly associated with childhood lung function (data not shown).
The significant associations observed between maternal zinc intake and the maternal antioxidant score
during pregnancy and childhood FEV1 and FVC remained unattenuated in all the sensitivity analyses (see
Statistical analyses section), whereas associations with the other dietary exposures weakened (data not
shown). The significant associations observed between maternal zinc intake and the maternal antioxidant
score and childhood FEV1 and FVC also remained unattenuated after adjusting for child dietary zinc
intake and antioxidant score, respectively, at age 3 years. In subsets of the cohort with complete data for
paternal (respectively, maternal) zinc intake after pregnancy, no association was found between paternal
(respectively, maternal) zinc intake or antioxidant score after pregnancy and childhood lung function (data
not shown). The inverse probability weighting analysis did not alter the main results (data not shown).
Post hoc analyses of the associations between maternal zinc intake and childhood FEV1 and FVC at
15 years (n=3669) showed similar findings to those observed at 8 years (difference in age-, height- and
sex-adjusted SD units per quartile increase in maternal dietary zinc intake β 0.06 (95% CI 0.01–0.11);
ptrend=0.01 and 0.06 (95% CI 0.01–0.10); ptrend=0.02, respectively). However, no association was found
between the maternal antioxidant score and childhood FEV1 and FVC at 15 years (data not shown).
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TABLE 1 Characteristics of mothers and offspring who were included and excluded in the
analyses#
Included Excluded p-value¶
Subjects n 8915 3163
Maternal intake in pregnancy
Vitamin C mg·day−1 82±35 74±36 <0.001
Vitamin E mg·day−1 8.7±4.1 8.0±4.1 <0.001
Zinc mg·day−1 8.3±2.4 7.8±2.4 <0.001
Selenium µg·day−1 72.2±27.9 66.1±27.2 <0.001
Carotene µg·day−1 2170±1176 2018±1175 <0.001
Fruits g·week−1 671±390 557±392 <0.001
Vegetables g·week−1 949±474 888±505 <0.001
Mother’s age years 28.9±4.6 26.5±5.1 <0.001
Parity




Male 51.1 52.2 0.28
Female 48.9 47.8
Multiple pregnancy
Singleton 97.6 97.1 0.14
Twin 2.4 2.9
Season of birth





Never 21.2 35.4 <0.001
<3 months 31.5 32.9
3– <6 months 13.8 10.4
⩾6 months 33.5 21.3
Mother’s educational level
Certificate of Secondary Education 15.4 32.7 <0.001
Vocational 9.0 12.2
Ordinary level 35.4 32.6
Advanced level 25.1 15.6
Degree 15.1 6.8
Maternal ethnicity
White 98.1 95.5 <0.001
Non-White 1.9 4.5
Housing tenure
Owned/mortgaged 83.7 62.5 <0.001
Council rented 9.4 24.0
Noncouncil rented 6.9 13.5
Financial difficulties
Yes 17.1 22.9 <0.001
Maternal history of atopic diseases
Yes 68.3 68.9 0.62
Maternal anxiety score in pregnancy




Maximum maternal tobacco exposure
None 26.5 17.5 <0.001
Passive only 46.0 36.1
1–9 cigarettes per day 8.0 9.5
10–19 cigarettes per day 11.3 19.9
⩾20 cigarettes per day 8.2 17.1
Maternal paracetamol use during pregnancy
Yes 62.4 64.6 0.03
Continued
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When we stratified maternal dietary associations by maternal smoking, there was no evidence of effect
modification by smoking on any childhood outcome (table 4). Conversely, when we stratified the
association between maternal smoking during pregnancy and childhood FEF25–75 (β per smoking category
increase in the whole cohort 0.05 (95% CI −0.07–−0.02); ptrend=0.0001) by maternal intake (above and
below median) of dietary antioxidants, associations between maternal smoking and childhood FEF25–75
were stronger for mothers with below median intakes of fruits, vitamin C, vitamin E and the maternal
antioxidant score, although there was no statistical evidence of interaction (supplementary table S1).
When the study population was restricted to mother–child pairs with complete data on maternal
genotype, the main findings described above were similar (results not shown). Maternal and child
genotype frequencies did not deviate significantly from Hardy–Weinberg equilibrium. When we stratified
associations between maternal intake of fruits and vegetables during pregnancy and childhood outcomes
by maternal GST gene polymorphisms, there was weak evidence for an interaction between vegetables
intake and GSTM1 genotype on FVC (pinteraction=0.07), with a positive association only if mothers were
GSTM1 null (table 5). When we investigated interactions between maternal intake of other antioxidants
and maternal GST gene polymorphisms on childhood outcomes, weak evidence was found for an
interaction between zinc and GSTM1 on childhood FVC (β 0.11 (95% CI 0.05–0.17); ptrend=0.001 and 0.02
(95% CI −0.05–0.08); ptrend=0.57, respectively, for the null and non-null maternal GSTM1 genotype
groups; pinteraction=0.05). No interaction was found between maternal intake of other antioxidant nutrients
or the antioxidant score and GST gene polymorphisms on any childhood outcome (data not shown). No
interaction was found between maternal intake of selenium during pregnancy and maternal GPX4
genotype on childhood outcomes (supplementary table S2). As a post hoc analysis, we studied the
associations between maternal zinc intake and childhood FVC, stratified by combinations of maternal and
child GSTM1 genotypes. We observed positive associations if mothers were GSTM1 null, regardless of the
TABLE 1 Continued
Included Excluded p-value¶
Maternal antibiotic use during pregnancy
Yes 16.1 14.5 0.04
Maternal vitamin/zinc supplement use during pregnancy
Yes 21.6 20.0 0.06
Maternal infections in pregnancy
Yes 45.8 46.9 0.27
Total energy intake kJ·day−1 7260±1966 7162±2153 0.02
Maternal pre-pregnancy BMI
<18.50 kg·m−2 4.3 6.4 <0.001
18.50–24.99 kg·m−2 75.4 72.8
25.00–29.99 kg·m−2 15.1 14.8
⩾30.00 kg·m−2 5.2 6.0
Birthweight
<2500 g 4.3 5.7 <0.001
2500–2999 g 13.8 15.2
3000–3499 g 35.4 36.6
3500–3999 g 33.2 30.8
⩾4000 g 13.3 11.7
Gestational age weeks 39.5±1.8 39.4±1.8 0.03
Child’s BMI at 7 years
<15.00 kg·m−2 28.1 29.6 0.51
15.00–17.49 kg·m−2 52.5 45.5
17.50–20.49 kg·m−2 15.2 19.3
⩾20.50 kg·m−2 4.2 5.7
Maternal weight gain during pregnancy
Quartile 1 25.3 28.4 <0.001
Quartile 2 24.8 24.4
Quartile 3 25.6 22.0
Quartile 4 24.4 25.2
Data are presented as mean±SD or %, unless otherwise stated. BMI: body mass index. #: n=12078;
¶: Chi-squared tests were used for categorical variables, and t-tests and Wilcoxon tests were used for
nonskewed- and skewed-distributed continuous variables, respectively.
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TABLE 2 Associations between maternal dietary antioxidant intake and childhood asthma and atopy
Asthma# Atopy¶
Model 1+ Model 2§ Model 1+ Model 2§
Total fruits
Quartile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Quartile 2 0.80 (0.61–1.05) 0.87 (0.66–1.15) 0.89 (0.68–1.16) 0.84 (0.63–1.10)
Quartile 3 0.73 (0.57–0.94) 0.86 (0.66–1.12) 1.06 (0.82–1.36) 0.92 (0.70–1.20)
Quartile 4 0.68 (0.52–0.88) 0.82 (0.62–1.10) 1.06 (0.82–1.37) 0.85 (0.65–1.13)
Per quartile 0.90 (0.83–0.97) 0.95 (0.88–1.04) 1.06 (0.99–1.13) 0.98 (0.91–1.06)
ptrend 0.004 0.26 0.12 0.58
Total vegetables
Quartile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Quartile 2 0.94 (0.77–1.15) 0.96 (0.79–1.18) 0.98 (0.82–1.18) 0.94 (0.78–1.14)
Quartile 3 0.90 (0.75–1.09) 0.93 (0.77–1.14) 0.96 (0.81–1.15) 0.90 (0.75–1.08)
Quartile 4 0.84 (0.69–1.02) 0.88 (0.71–1.08) 1.07 (0.89–1.28) 0.96 (0.79–1.15)
Per quartile 0.95 (0.89–1.01) 0.96 (0.90–1.02) 1.02 (0.96–1.08) 0.98 (0.93–1.04)
ptrend 0.08 0.22 0.52 0.57
Vitamin C
Quartile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Quartile 2 0.83 (0.68–1.02) 0.90 (0.74–1.11) 1.03 (0.85–1.24) 0.94 (0.78–1.14)
Quartile 3 0.86 (0.70–1.04) 0.98 (0.79–1.20) 1.06 (0.88–1.28) 0.93 (0.76–1.13)
Quartile 4 0.77 (0.63–0.95) 0.89 (0.71–1.11) 1.20 (0.99–1.44) 0.98 (0.80–1.20)
Per quartile 0.93 (0.87–0.99) 0.97 (0.91–1.05) 1.06 (1.00–1.13) 1.00 (0.93–1.06)
ptrend 0.03 0.46 0.05 0.93
Vitamin E
Quartile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Quartile 2 0.83 (0.67–1.02) 0.90 (0.73–1.12) 1.03 (0.86–1.25) 0.97 (0.80–1.17)
Quartile 3 1.06 (0.87–1.31) 1.18 (0.95–1.46) 1.10 (0.91–1.32) 1.00 (0.82–1.22)
Quartile 4 0.88 (0.70–1.10) 0.99 (0.78–1.26) 1.12 (0.91–1.37) 0.99 (0.80–1.22)
Per quartile 0.99 (0.92–1.06) 1.03 (0.95–1.11) 1.04 (0.98–1.11) 1.00 (0.94–1.07)
ptrend 0.80 0.46 0.23 0.98
Zinc
Quartile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Quartile 2 1.05 (0.85–1.30) 1.15 (0.92–1.43) 1.00 (0.82–1.21) 0.91 (0.75–1.11)
Quartile 3 1.01 (0.80–1.27) 1.15 (0.90–1.47) 1.13 (0.92–1.40) 0.98 (0.78–1.22)
Quartile 4 0.97 (0.73–1.30) 1.15 (0.85–1.57) 1.07 (0.82–1.38) 0.85 (0.64–1.12)
Per quartile 0.99 (0.90–1.08) 1.04 (0.94–1.15) 1.04 (0.95–1.13) 0.96 (0.88–1.05)
ptrend 0.78 0.42 0.39 0.41
Selenium
Quartile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Quartile 2 0.95 (0.77–1.17) 1.04 (0.84–1.29) 1.09 (0.90–1.31) 1.00 (0.83–1.22)
Quartile 3 0.95 (0.77–1.18) 1.04 (0.83–1.31) 1.14 (0.94–1.39) 0.99 (0.80–1.21)
Quartile 4 0.90 (0.71–1.15) 1.03 (0.79–1.35) 1.07 (0.86–1.33) 0.87 (0.68–1.10)
Per quartile 0.97 (0.90–1.05) 1.01 (0.93–1.10) 1.02 (0.95–1.10) 0.95 (0.89–1.03)
ptrend 0.44 0.83 0.53 0.23
Carotene
Quartile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Quartile 2 0.95 (0.78–1.15) 0.94 (0.77–1.15) 0.91 (0.76–1.09) 0.91 (0.75–1.09)
Quartile 3 0.91 (0.74–1.10) 0.94 (0.77–1.16) 1.03 (0.87–1.23) 1.01 (0.84–1.21)
Quartile 4 0.89 (0.73–1.09) 0.93 (0.75–1.14) 1.00 (0.84–1.20) 0.93 (0.77–1.12)
Per quartile 0.96 (0.90–1.02) 0.98 (0.91–1.05) 1.01 (0.96–1.07) 0.99 (0.93–1.05)
ptrend 0.23 0.51 0.67 0.68
Antioxidant score
Quartile 1 1.00 (reference) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Quartile 2 0.98 (0.79–1.21) 1.09 (0.88–1.36) 1.04 (0.85–1.27) 0.94 (0.76–1.15)
Quartile 3 0.91 (0.72–1.15) 1.06 (0.83–1.37) 1.20 (0.96–1.48) 1.00 (0.80–1.26)
Quartile 4 0.81 (0.62–1.05) 0.98 (0.74–1.31) 1.19 (0.94–1.51) 0.92 (0.71–1.20)
Per quartile 0.93 (0.86–1.01) 0.98 (0.90–1.08) 1.07 (0.99–1.15) 0.98 (0.91–1.07)
ptrend 0.07 0.72 0.08 0.70
Data are presented as odds ratio (95% CI), unless otherwise stated. #: n=7677; ¶: n=6117; +: model
controlling for energy intake only; §: model controlling for energy intake, smoking, infections,
supplements, antibiotics and paracetamol use during pregnancy, and maternal educational level, housing
tenure, financial difficulties, ethnicity, age, parity, history of atopic diseases, anxiety, sex of child, season of
birth, multiple pregnancy and breastfeeding duration.
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TABLE 3 Associations between maternal dietary antioxidant intake and childhood lung function
FEV1 FVC FEF25–75
Model 1# Model 2¶ Model 1# Model 2¶ Model 1# Model 2¶
Subjects n 6062 6157 6157
Total fruits
Quartile 1 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference)
Quartile 2 −0.02 (−0.13–0.09) −0.03 (−0.14–0.08) −0.01 (−0.11–0.08) −0.04 (−0.15–0.07) −0.01 (−0.12–0.10) −0.03 (−0.14–0.08)
Quartile 3 0.04 (−0.06–0.15) 0.02 (−0.09–0.12) −0.01 (−0.10–0.07) −0.03 (−0.14–0.08) 0.07 (−0.04–0.17) 0.04 (−0.07–0.14)
Quartile 4 0.06 (−0.05–0.17) 0.03 (−0.09–0.14) 0.04 (−0.05–0.13) 0.02 (−0.10–0.13) 0.05 (−0.06–0.15) 0.01 (−0.10–0.13)
Per quartile 0.03 (0.00–0.06) 0.02 (−0.01–0.05) 0.02 (0.00–0.05) 0.02 (−0.01–0.05) 0.02 (−0.01–0.05) 0.01 (−0.02–0.04)
ptrend 0.04 0.25 0.09 0.26 0.12 0.41
Total vegetables
Quartile 1 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference)
Quartile 2 0.06 (−0.01–0.14) 0.05 (−0.03–0.13) 0.02 (−0.05–0.10) 0.02 (−0.06–0.09) 0.08 (0.00–0.15) 0.06 (−0.02–0.14)
Quartile 3 0.02 (−0.05–0.09) 0.01 (−0.07–0.08) −0.01 (−0.08–0.06) −0.02 (−0.09–0.05) 0.06 (−0.01–0.13) 0.05 (−0.03–0.12)
Quartile 4 0.10 (0.03–0.17) 0.08 (0.01–0.16) 0.07 (0.00–0.15) 0.06 (−0.01–0.14) 0.10 (0.03–0.18) 0.09 (0.01–0.16)
Per quartile 0.03 (0.00–0.05) 0.02 (0.00–0.05) 0.02 (0.00–0.04) 0.01 (−0.01–0.04) 0.03 (0.01–0.05) 0.02 (0.00–0.05)
ptrend 0.03 0.09 0.12 0.22 0.01 0.05
Vitamin C
Quartile 1 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference)
Quartile 2 0.05 (−0.02–0.13) 0.04 (−0.04–0.12) 0.06 (−0.01–0.14) 0.05 (−0.02–0.13) 0.02 (−0.05–0.10) 0.01 (−0.07–0.09)
Quartile 3 0.05 (−0.03–0.12) 0.02 (−0.05–0.10) 0.05 (−0.02–0.12) 0.03 (−0.04–0.11) 0.02 (−0.05–0.10) 0.00 (−0.07–0.08)
Quartile 4 0.06 (−0.02–0.14) 0.04 (−0.05–0.12) 0.05 (−0.02–0.13) 0.04 (−0.05–0.12) 0.05 (−0.02–0.13) 0.03 (−0.05–0.12)
Per quartile 0.02 (−0.01–0.04) 0.01 (−0.02–0.03) 0.01 (−0.01–0.04) 0.01 (−0.02–0.03) 0.02 (−0.01–0.04) 0.01 (−0.02–0.04)
ptrend 0.17 0.53 0.30 0.62 0.19 0.45
Vitamin E
Quartile 1 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference)
Quartile 2 −0.03 (−0.10–0.05) −0.03 (−0.11–0.04) 0.00 (−0.07–0.08) 0.01 (−0.07–0.08) −0.02 (−0.09–0.06) −0.04 (−0.11–0.04)
Quartile 3 −0.02 (−0.10–0.06) −0.03 (−0.11–0.05) 0.02 (−0.06–0.10) 0.02 (−0.06–0.10) −0.02 (−0.10–0.05) −0.05 (−0.13–0.03)
Quartile 4 0.01 (−0.07–0.10) −0.01 (−0.09–0.08) 0.04 (−0.04–0.13) 0.04 (−0.04–0.13) 0.00 (−0.08–0.09) −0.03 (−0.12–0.05)
Per quartile 0.01 (−0.02–0.03) 0.00 (−0.03–0.03) 0.01 (−0.01–0.04) 0.01 (−0.01–0.04) 0.00 (−0.02–0.03) −0.01 (−0.04–0.02)
ptrend 0.63 0.98 0.26 0.28 0.90 0.48
Zinc
Quartile 1 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference)
Quartile 2 0.05 (−0.03–0.13) 0.04 (−0.04–0.12) 0.04 (−0.04–0.12) 0.03 (−0.05–0.11) 0.05 (−0.03–0.13) 0.03 (−0.05–0.11)
Quartile 3 0.11 (0.02–0.20) 0.08 (−0.01–0.17) 0.13 (0.04–0.21) 0.11 (0.02–0.20) 0.06 (−0.03–0.15) 0.02 (−0.07–0.11)
Quartile 4 0.18 (0.07–0.29) 0.14 (0.03–0.25) 0.16 (0.05–0.26) 0.14 (0.03–0.25) 0.13 (0.02–0.23) 0.07 (−0.04–0.18)
Per quartile 0.06 (0.03–0.09) 0.05 (0.01–0.08) 0.06 (0.02–0.09) 0.05 (0.02–0.09) 0.04 (0.00–0.07) 0.02 (−0.02–0.06)
ptrend 0.001 0.01 0.001 0.005 0.03 0.28
Selenium
Quartile 1 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference)
Quartile 2 0.05 (−0.03–0.13) 0.03 (−0.05–0.11) 0.05 (−0.03–0.13) 0.05 (−0.03–0.13) 0.04 (−0.04–0.12) 0.00 (−0.07–0.08)
Quartile 3 0.06 (−0.02–0.14) 0.04 (−0.04–0.13) 0.05 (−0.03–0.13) 0.05 (−0.04–0.18) 0.06 (−0.02–0.14) 0.02 (−0.07–0.10)
Quartile 4 0.09 (0.00–0.18) 0.06 (−0.03–0.16) 0.11 (0.02–0.20) 0.10 (0.01–0.20) 0.05 (−0.04–0.14) −0.01 (−0.10–0.09)
Per quartile 0.03 (0.00–0.06) 0.02 (−0.01–0.05) 0.03 (0.00–0.06) 0.03 (0.00–0.06) 0.02 (−0.01–0.05) 0.00 (−0.03–0.03)
ptrend 0.05 0.22 0.03 0.06 0.25 0.95
Carotene
Quartile 1 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference)
Quartile 2 0.01 (−0.07–0.08) −0.01 (−0.09–0.06) 0.02 (−0.05–0.09) 0.01 (−0.06–0.09) −0.02 (−0.09–0.05) −0.05 (−0.12–0.02)
Quartile 3 0.05 (−0.02–0.12) 0.03 (−0.05–0.10) 0.02 (−0.05–0.10) 0.01 (−0.06–0.09) 0.03 (−0.04–0.11) 0.00 (−0.07–0.07)
Quartile 4 0.10 (0.03–0.18) 0.08 (0.01–0.16) 0.08 (0.01–0.16) 0.08 (0.00–0.15) 0.07 (0.00–0.15) 0.04 (−0.03–0.12)
Per quartile 0.04 (0.01–0.06) 0.03 (0.00–0.05) 0.03 (0.00–0.05) 0.02 (0.00–0.05) 0.03 (0.00–0.05) 0.02 (−0.01–0.04)
ptrend 0.004 0.02 0.03 0.05 0.03 0.17
Antioxidant score
Quartile 1 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference) 0.00 (reference)
Quartile 2 −0.01 (−0.09–0.07) −0.03 (−0.11–0.06) 0.01 (−0.07–0.09) 0.02 (−0.06–0.10) −0.01 (−0.09–0.07) −0.04 (−0.13–0.04)
Quartile 3 0.03 (−0.06–0.12) 0.01 (−0.09–0.10) 0.03 (−0.05–0.12) 0.04 (−0.06–0.13) 0.04 (−0.05–0.12) −0.01 (−0.10–0.09)
Quartile 4 0.12 (0.02–0.22) 0.08 (−0.02–0.19) 0.13 (0.03–0.22) 0.12 (0.02–0.23) 0.07 (−0.03–0.17) 0.01 (−0.10–0.12)
Per quartile 0.04 (0.01–0.08) 0.03 (0.00–0.07) 0.04 (0.01–0.07) 0.04 (0.01–0.07) 0.03 (0.00–0.06) 0.01 (−0.02–0.04)
ptrend 0.004 0.04 0.005 0.01 0.06 0.52
Data are presented as β (difference in age-, height- and sex-adjusted SD units) (95% CI), unless otherwise stated. FEV1: forced expiratory
volume in 1 s; FVC: forced vital capacity; FEF25–75: forced expiratory flow at 25–75% of FVC. #: model controlling for energy intake only;
¶: model controlling for energy intake, smoking, infections, supplements, antibiotics and paracetamol use during pregnancy, and maternal
educational level, housing tenure, financial difficulties, ethnicity, age, parity, history of atopic diseases, anxiety, sex of child, season of birth,
multiple pregnancy and breastfeeding duration.
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child’s GSTM1 genotype (table 6). Post hoc analysis did not show evidence of an interaction between
maternal zinc intake and maternal GSTM1 on childhood FVC at 15 years (pinteraction=0.16).
Discussion
In this large, population-based, birth cohort study, we found that a higher maternal zinc intake during
pregnancy was associated, in a dose–response fashion, with higher FEV1 and FVC in the offspring, after
controlling for potential confounders. To the best of our knowledge this is a novel finding. Only one other
birth cohort study has investigated the relation between maternal diet in pregnancy and childhood lung
function, and did not report any association between maternal zinc intake and lung function in the
offspring at age 5 years [2], but the sample size was much smaller than ours. We also found weak evidence
for an interaction between maternal zinc intake during pregnancy and maternal GSTM1 genotype on
childhood FVC. Interactions between maternal intake of antioxidants and antioxidant genotype on
childhood lung function and other respiratory and atopic outcomes have not previously been investigated.
The graded nature of the associations between maternal zinc intake and lung function is in keeping with a
causal effect on lung growth and development, and persistence of the association from childhood to
adolescence strengthens causal inference further. While we also found positive associations between the
maternal antioxidant score during pregnancy (derived from five antioxidant nutrients) and childhood lung
function, these were largely explained by maternal zinc intake.
TABLE 4 Associations between maternal dietary antioxidant intake and childhood outcomes stratified by maternal smoking
during pregnancy
Asthma Atopy FEV1 FVC FEF25−75
OR# (95% CI) ptrend OR# (95% CI) ptrend β# (95% CI) ptrend β# (95% CI) ptrend β# (95% CI) ptrend
Subjects n 7677 6117 6062 6157 6157
Total fruits intake
Non/passive smokers 0.99 (0.89–1.09) 0.81 1.02 (0.93–1.12) 0.61 0.02 (−0.02–0.05) 0.41 0.02 (−0.02–0.05) 0.35 0.01 (−0.02–0.05) 0.43
Active smokers 0.90 (0.78–1.04) 0.16 0.87 (0.76–1.01) 0.07 0.02 (−0.04–0.08) 0.49 0.02 (−0.04–0.08) 0.45 0.00 (−0.06–0.06) 1.00
pinteraction¶ 0.59 0.14 0.60 0.90 0.93
Total vegetables intake
Non/passive smokers 1.00 (0.92–1.08) 0.91 0.99 (0.93–1.06) 0.85 0.02 (−0.01–0.05) 0.15 0.02 (−0.01–0.05) 0.16 0.02 (−0.01–0.04) 0.23
Active smokers 0.88 (0.78–1.00) 0.05 0.94 (0.83–1.07) 0.34 0.02 (−0.03–0.07) 0.36 0.00 (−0.05–0.05) 0.96 0.04 (0.00–0.09) 0.07
pinteraction¶ 0.18 0.70 0.96 0.35 0.25
Vitamin C intake
Non/passive smokers 1.00 (0.92–1.09) 0.99 1.01 (0.94–1.09) 0.75 0.00 (−0.03–0.03) 0.81 0.01 (−0.02–0.04) 0.53 0.00 (−0.03–0.03) 0.86
Active smokers 0.92 (0.81–1.05) 0.23 0.93 (0.82–1.06) 0.30 0.02 (−0.03–0.07) 0.49 0.00 (−0.05–0.05) 0.95 0.02 (−0.03–0.07) 0.41
pinteraction¶ 0.54 0.57 0.55 0.65 0.30
Vitamin E intake
Non/passive smokers 1.06 (0.97–1.16) 0.19 0.97 (0.90–1.05) 0.44 0.00 (−0.03–0.03) 0.96 0.02 (−0.01–0.05) 0.25 −0.01 (−0.05–0.02) 0.38
Active smokers 0.96 (0.84–1.11) 0.60 1.12 (0.98–1.28) 0.11 0.00 (−0.06–0.05) 0.91 0.00 (−0.05–0.05) 0.95 0.00 (−0.05–0.06) 0.94
pinteraction¶ 0.39 0.09 0.83 0.51 0.53
Zinc intake
Non/passive smokers 1.06 (0.94–1.19) 0.36 0.96 (0.86–1.06) 0.39 0.04 (0.00–0.08) 0.05 0.05 (0.01–0.09) 0.02 0.01 (−0.03–0.05) 0.58
Active smokers 1.01 (0.85–1.21) 0.90 1.01 (0.85–1.21) 0.90 0.05 (−0.02–0.12) 0.15 0.05 (−0.02–0.12) 0.14 0.04 (−0.03–0.11) 0.30
pinteraction¶ 0.92 0.61 0.74 0.72 0.76
Selenium intake
Non/passive smokers 0.99 (0.90–1.10) 0.87 0.93 (0.86–1.02) 0.12 0.03 (−0.01–0.06) 0.13 0.03 (0.00–0.07) 0.07 0.01 (−0.03–0.04) 0.76
Active smokers 1.05 (0.90–1.22) 0.56 1.03 (0.89–1.19) 0.72 0.00 (−0.06–0.06) 0.93 0.03 (−0.03–0.08) 0.40 −0.01 (−0.07–0.04) 0.64
pinteraction¶ 0.50 0.31 0.32 0.52 0.67
Carotene intake
Non/passive smokers 0.98 (0.91–1.07) 0.70 0.98 (0.91–1.05) 0.53 0.02 (0.00–0.05) 0.10 0.02 (−0.01–0.05) 0.12 0.01 (−0.02–0.04) 0.52
Active smokers 0.97 (0.85–1.10) 0.59 1.02 (0.90–1.15) 0.78 0.04 (−0.01–0.09) 0.11 0.03 (−0.02–0.08) 0.25 0.04 (−0.01–0.08) 0.15
pinteraction¶ 0.83 0.47 0.75 0.85 0.32
Antioxidant score
Non/passive smokers 1.01 (0.91–1.13) 0.85 0.96 (0.87–1.05) 0.35 0.03 (−0.01–0.07) 0.18 0.04 (0.00–0.08) 0.03 0.00 (−0.04–0.04) 0.93
Active smokers 0.94 (0.80–1.11) 0.44 1.08 (0.92–1.27) 0.37 0.05 (−0.01–0.11) 0.13 0.04 (−0.03–0.10) 0.23 0.04 (−0.02–0.10) 0.22
pinteraction¶ 0.70 0.25 0.86 0.64 0.35
β: difference in age-, height- and sex-adjusted SD units; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; FEF25–75: forced
expiratory flow at 25–75% of FVC. #: per category/quartile of dietary intake, controlling for energy intake, infections, supplements, antibiotics
and paracetamol use during pregnancy, and maternal educational level, housing tenure, financial difficulties, ethnicity, age, parity, history of
atopic diseases, anxiety, sex of child, season of birth, multiple pregnancy and breastfeeding duration; ¶: treating smoking as a binary variable
and dietary exposures as continuous variables.
https://doi.org/10.1183/13993003.00507-2018 9
PAEDIATRICS AND ASTHMA | A. BÉDARD ET AL.
A surprising observation was the lack of interaction between maternal intake of antioxidants and maternal
smoking on childhood outcomes. We hypothesised that a higher intake of antioxidants might be particularly
beneficial if the fetus was exposed to tobacco smoke, a source of oxidative stress, but no such effect
modification was seen. To the best of our knowledge, this has not been investigated before. However, when
we examined the detrimental effect of maternal smoking on FEF25–75, we found that effect estimates were
generally larger if mothers had below average intakes of antioxidants, especially vitamin C and vitamin E,
than if their intakes were above average. While these differences were not statistically significant on formal
testing for interaction, they are in keeping with a trial in pregnant smokers which showed that the detrimental
effect of smoking on infant lung function was reduced by vitamin C supplementation in pregnancy [11]. One
possible explanation for why we did not see a statistically significant interaction between antioxidant intake
and smoking is that the estimated maximum vitamin C intake from food alone in ALSPAC pregnant females
was 256 mg·day−1, which is much lower than the 500 mg daily intake of vitamin C taken by mothers in the
trial [11], although ∼20% of ALSPAC females were also taking vitamin supplements.
While some studies have suggested a possible protective effect of maternal intake of vitamin E, zinc, fruits
and vegetables during pregnancy on childhood asthma and atopy [2–4], we found no evidence to support
this, nor were the other antioxidant nutrients associated with these outcomes, which is concordant with two
recent systematic reviews and meta-analyses [5, 43]. Given the size of our study, we therefore believe that
the new totality of evidence (including ALSPAC) indicates that there is unlikely to be a causal relationship
between dietary antioxidant intake in pregnancy and risk of childhood asthma and atopy.
Mechanisms
A plausible explanation for the associations we observed between maternal zinc intake during pregnancy
and childhood lung function, and especially FVC, could be that pre-natal zinc status influences growth
TABLE 5 Associations between maternal fruits and vegetables intake and childhood outcomes stratified by maternal
glutathione S-transferase gene polymorphisms
Asthma Atopy FEV1 FVC FEF25−75
OR# (95% CI) ptrend OR# (95% CI) ptrend β# (95% CI) ptrend β# (95% CI) ptrend β# (95% CI) ptrend
Subjects 4953 3911 4011 4080 4080
Total fruits intake
GSTT1
Non-null (n=4376) 0.91 (0.81–1.02) 0.10 1.01 (0.90–1.12) 0.92 0.01 (−0.03–0.06) 0.52 0.02 (−0.02–0.06) 0.39 0.00 (−0.04–0.04) 0.95
Null (n=870) 1.00 (0.77–1.30) 0.99 0.92 (0.71–1.18) 0.49 0.04 (−0.06–0.14) 0.42 0.04 (−0.06–0.13) 0.48 0.04 (−0.06–0.14) 0.46
pinteraction 0.71 0.47 0.44 0.50 0.48
GSTM1
Non-null (n=2476) 0.84 (0.72–0.98) 0.03 1.01 (0.87–1.17) 0.93 0.01 (−0.05–0.06) 0.77 0.03 (−0.03–0.08) 0.30 −0.03 (−0.09–0.03) 0.29
Null (n=2799) 0.94 (0.82–1.09) 0.44 0.98 (0.85–1.12) 0.73 0.04 (−0.02–0.09) 0.20 0.02 (−0.03–0.08) 0.46 0.04 (−0.01–0.10) 0.13
pinteraction 0.12 0.54 0.53 0.87 0.26
GSTP1, rs1695
A:A (n=2289) 0.96 (0.81–1.13) 0.61 0.99 (0.85–1.16) 0.94 0.01 (−0.05–0.07) 0.66 0.01 (−0.05–0.07) 0.75 0.02 (−0.04–0.08) 0.47
G:A (n=2529) 0.91 (0.78–1.06) 0.23 0.98 (0.85–1.13) 0.76 0.02 (−0.04–0.08) 0.55 0.02 (−0.04–0.08) 0.46 0.00 (−0.06–0.06) 0.97
G:G (n=670) 0.83 (0.61–1.13) 0.25 0.80 (0.59–1.10) 0.17 0.00 (−0.11–0.12) 0.94 0.01 (−0.10–0.12) 0.83 0.01 (−0.11–0.13) 0.85
pinteraction 0.60 0.94 0.59 0.87 0.31
Total vegetables intake
GSTT1
Non-null (n=4376) 0.91 (0.83–1.00) 0.05 1.01 (0.93–1.10) 0.85 0.04 (0.00–0.07) 0.03 0.05 (0.01–0.07) 0.006 0.02 (−0.01–0.05) 0.21
Null (n=870) 1.00 (0.80–1.25) 0.98 0.99 (0.80–1.23) 0.95 0.01 (−0.07–0.09) 0.84 −0.03 (−0.11–0.05) 0.46 0.04 (−0.04–0.12) 0.30
pinteraction 0.25 0.98 0.81 0.22 0.68
GSTM1
Non-null (n=2476) 0.90 (0.79–1.02) 0.09 0.96 (0.86–1.08) 0.54 0.01 (−0.03–0.06) 0.54 0.01 (−0.03–0.05) 0.59 0.03 (−0.01–0.07) 0.19
Null (n=2799) 0.94 (0.84–1.06) 0.32 1.05 (0.95–1.17) 0.33 0.06 (0.01–0.10) 0.01 0.06 (0.02–0.10) 0.004 0.02 (−0.02–0.06) 0.41
pinteraction 0.52 0.15 0.24 0.07 0.41
GSTP1, rs1695
A:A (n=2289) 0.98 (0.86–1.12) 0.76 1.02 (0.90–1.15) 0.77 0.06 (0.01–0.11) 0.01 0.06 (0.02–0.11) 0.008 0.04 (−0.01–0.08) 0.12
G:A (n=2529) 0.98 (0.87–1.10) 0.72 1.06 (0.94–1.18) 0.33 0.02 (−0.03–0.06) 0.41 0.02 (−0.02–0.07) 0.27 0.00 (−0.04–0.05) 0.88
G:G (n=670) 0.89 (0.69–1.15) 0.37 0.81 (0.64–1.02) 0.08 0.01 (−0.07–0.10) 0.78 −0.01 (−0.10–0.07) 0.76 0.06 (−0.03–0.15) 0.21
pinteraction 0.42 0.19 0.35 0.18 0.82
β: difference in age-, height- and sex-adjusted SD units; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; FEF25–75: forced
expiratory flow at 25–75% of FVC. #: per category/quartile of fruits/vegetables intake, controlling for energy intake, smoking, infections,
supplements, antibiotics and paracetamol use during pregnancy, and maternal educational level, housing tenure, financial difficulties, ethnicity,
age, parity, history of atopic diseases, anxiety, sex of child, season of birth, multiple pregnancy and breastfeeding duration.
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and development of fetal lungs. In support of this hypothesis, zinc deficiency has been associated with
impaired fetal lung growth in rats [44]. According to the FFQ completed in pregnancy, the main sources
of dietary zinc were red meat and poultry in ALSPAC pregnant females. Although zinc is generally
considered to be an antioxidant, it can serve such a function only indirectly and the term
“pro-antioxidant” is more appropriate [45]. While the interaction between maternal zinc intake and
maternal GSTM1 genotype on childhood FVC is in keeping with a pro-antioxidant effect of zinc on
pre-natal lung growth (stronger association if the mother was GSTM1 null and therefore had compromised
enzymatic antioxidant defences), the lack of effect modification by maternal smoking and the lack of effect
modification by maternal GSTM1 genotype on FVC in adolescence do not support such an interpretation.
However, zinc influences growth through multiple, complex pathways [46] and effects on fetal lung growth
may not involve its pro-antioxidant properties.
Strengths and limitations
Strengths of the ALSPAC birth cohort include its population-based prospective design, rich information
on numerous potential confounders and detailed phenotypic outcome measurements. ALSPAC’s size gave
us greater statistical power than previous, smaller birth cohorts that have investigated this research
question. Another major strength of the ALSPAC birth cohort is that maternal DNA was collected,
enabling maternal genotyping and exploration of interactions with pre-natal exposures, which is not
possible in most other birth cohort studies.
Although the FFQ that we used had not been formally calibrated against other instruments such as diet
diaries, it was based on the one used by YARNELL et al. [47], which has been validated against weighed
dietary records, and modified in the light of a more recent weighed dietary survey [21]. While there will
have been some misclassification of dietary exposures, this is likely to be nondifferential with respect to the
outcomes of interest and would be expected to bias effect estimates towards the null; in other words, the
magnitude of associations may have been underestimated and small or modest effects may have been
missed. The possibility of uncontrolled or residual confounding cannot be ruled out. However, we think
that confounding of the main findings by lifestyle or other aspects of maternal diet in pregnancy is
unlikely, as we controlled for numerous potential confounders in the analyses, including post-natal zinc
intake. The null findings for maternal and paternal zinc intakes after pregnancy make confounding by
unmeasured familial behaviours linked to zinc intake and offspring lung function a less likely explanation
for the main findings.
As with any longitudinal study, we cannot rule out the possibility that exclusion of mother–child pairs
without complete information might have biased our findings. However, it could be argued that, for our
results to be totally spurious for maternal zinc intake and childhood lung function in those included in
our analysis (and for the associations to be truly null in the population as a whole), associations in the
excluded mother–child pairs would have to be at least of equal magnitude in the opposite direction, which
seems unlikely. Furthermore, loss to follow-up bias has been shown to only slightly modify associations in
longitudinal studies, including in ALSPAC [48], and the results of our inverse probability weighting
analysis confirmed that loss to follow-up is unlikely to have biased our results. In view of the multiple
analyses carried out, we cannot exclude the possibility that the main findings occurred by chance; hence,
they should be interpreted with caution and require replication in another birth cohort study. Given the a
priori nature of the general hypothesis being tested and the fact that some outcomes of interest were
highly correlated, it did not seem appropriate to correct for multiple testing.
TABLE 6 Associations between maternal zinc intake and childhood forced vital capacity (FVC)
stratified by combinations of maternal and child glutathione S-transferase GSTM1 genotypes
GSTM1 n FVC#
Mother Child β¶ (95% CI) ptrend
Non-null Non-null 956 0.04 (−0.12–0.05) 0.41
Non-null Null 452 0.04 (−0.11–0.18) 0.60
Null Non-null 439 0.13 (−0.01–0.27) 0.07
Null Null 1167 0.15 (0.07–0.23) 0.0002
β: difference in age-, height- and sex-adjusted SD units. #: n=3014; ¶: per quartile of zinc intake, controlling
for energy intake, smoking, infections, supplements, antibiotics and paracetamol use during pregnancy,
and maternal educational level, housing tenure, financial difficulties, ethnicity, age, parity, history of atopic
diseases, anxiety, sex of child, season of birth, multiple pregnancy and breastfeeding duration.
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Conclusions
We conclude that a higher maternal intake of zinc during pregnancy may improve lung function, and
especially FVC, in the offspring, but further studies are needed to confirm these results. A Mendelian
randomisation approach could be used to strengthen causal inference. If the association with pre-natal zinc
status is causal, this may have greater implications in developing countries where zinc deficiency is a
bigger problem today than it is in the West [49]. In contrast, we found no evidence that maternal dietary
antioxidant intake in pregnancy is associated with risk of childhood asthma or atopy, suggesting that
intervening in pregnancy to increase antioxidant intake would be unlikely to succeed as a strategy to
prevent these conditions.
Acknowledgements: We are extremely grateful to all the families who took part in this study, the midwives for their help
in recruiting them and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians,
clerical workers, research scientists, volunteers, managers, receptionists, and nurses. This paper is the work of the
authors, and A.J. Henderson and S.O. Shaheen will serve as guarantors for its contents. The views expressed are those of
the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Dept of Health.
Author contributions: A. Bédard and S.O. Shaheen conceived the study and drafted the manuscript. All authors were
involved in the analysis strategy, K. Northstone gave advice on the dietary data, and A. Bédard performed the statistical
analyses. A.J. Henderson was responsible for all clinical respiratory and allergy data collection. J.W. Holloway was
responsible for generation of the genotyping data. All authors participated in the interpretation of the findings, reviewed
the manuscript and revised it critically before submission. All authors have seen and approved the final version of the
manuscript.
Conflict of interest: A.J. Henderson reports grants from the Medical Research Council and Wellcome, during the
conduct of the study.
Support statement: The UK Medical Research Council, the Wellcome Trust (grant 102215/2/13/2) and the University of
Bristol currently provide core support for ALSPAC. A. Bédard is funded by a European Respiratory Society Long-Term
Research Fellowship (LTRF 2015-5838). Funding information for this article has been deposited with the Crossref
Funder Registry.
References
1 Seaton A, Godden DJ, Brown K. Increase in asthma: a more toxic environment or a more susceptible population?
Thorax 1994; 49: 171–174.
2 Devereux G, Turner SW, Craig LC, et al. Low maternal vitamin E intake during pregnancy is associated with
asthma in 5-year-old children. Am J Respir Crit Care Med 2006; 174: 499–507.
3 Nurmatov U, Devereux G, Sheikh A. Nutrients and foods for the primary prevention of asthma and allergy:
systematic review and meta-analysis. J Allergy Clin Immunol 2011; 127: 724–733.
4 Garcia-Larsen V, Del Giacco SR, Moreira A, et al. Asthma and dietary intake: an overview of systematic reviews.
Allergy 2016; 71: 433–442.
5 Beckhaus AA, Garcia-Marcos L, Forno E, et al. Maternal nutrition during pregnancy and risk of asthma, wheeze,
and atopic diseases during childhood: a systematic review and meta-analysis. Allergy 2015; 70: 1588–1604.
6 Willett W. Nutritional epidemiology: issues and challenges. Int J Epidemiol 1987; 16: 312–317.
7 Romieu I, Castro-Giner F, Kunzli N, et al. Air pollution, oxidative stress and dietary supplementation: a review.
Eur Respir J 2008; 31: 179–197.
8 Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and
wheeze: systematic review and meta-analysis. Pediatrics 2012; 129: 735–744.
9 Guerra S, Stern DA, Zhou M, et al. Combined effects of parental and active smoking on early lung function
deficits: a prospective study from birth to age 26 years. Thorax 2013; 68: 1021–1028.
10 Henderson AJ, Newson RB, Rose-Zerilli M, et al. Maternal Nrf2 and gluthathione-S-transferase polymorphisms
do not modify associations of prenatal tobacco smoke exposure with asthma and lung function in school-aged
children. Thorax 2010; 65: 897–902.
11 McEvoy CT, Schilling D, Clay N, et al. Vitamin C supplementation for pregnant smoking women and pulmonary
function in their newborn infants. JAMA 2014; 311: 2074.
12 Chung J, Kwon SO, Ahn H, et al. Association between dietary patterns and atopic dermatitis in relation to
GSTM1 and GSTT1 polymorphisms in young children. Nutrients 2015; 7: 9440–9452.
13 Gref A, Rautiainen S, Gruzieva O, et al. Dietary total antioxidant capacity in early school age and subsequent
allergic disease. Clin Exp Allergy 2017; 47: 751–759.
14 Romieu I, Sienra-Monge JJ, Ramírez-Aguilar M, et al. Genetic polymorphism of GSTM1 and antioxidant
supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City.
Thorax 2004; 59: 8–10.
15 Boyd A, Golding J, Macleod J, et al. Cohort profile: the “Children of the 90s” – the index offspring of the Avon
Longitudinal Study of Parents and Children. Int J Epidemiol 2013; 42: 111–127.
16 Fraser A, Macdonald-Wallis C, Tilling K, et al. Cohort profile: the Avon Longitudinal Study of Parents and
Children: ALSPAC mothers cohort. Int J Epidemiol 2013; 42: 97–110.
17 Cornish RP, Henderson J, Boyd AW, et al. Validating childhood asthma in an epidemiological study using linked
electronic patient records. BMJ Open 2014; 4: e005345.
18 Chinn S, Rona RJ. Height and age adjustment for cross sectional studies of lung function in children aged 6–11
years. Thorax 1992; 47: 707–714.
19 American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:
1107–1136.
https://doi.org/10.1183/13993003.00507-2018 12
PAEDIATRICS AND ASTHMA | A. BÉDARD ET AL.
20 Arets HGM, Brackel HJL, Van Der Ent CK. Forced expiratory manoeuvres in children: do they meet ATS and ERS
criteria for spirometry? Eur Respir J 2001; 18: 655–660.
21 Rogers I, Emmett P. Diet during pregnancy in a population of pregnant women in South West England. ALSPAC
Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Eur J Clin Nutr 1998; 52: 246–250.
22 Ministry of Agriculture, Fisheries and Food. Food Portion Sizes. London, HMSO, 1991.
23 Ministry of Agriculture, Fisheries and Food. McCance and Widdowson’s The Composition of Foods. 5th Edn.
London, Royal Society of Chemistry, 1991.
24 Rose-Zerilli MJ, Barton SJ, Henderson AJ, et al. Copy-number variation genotyping of GSTT1 and GSTM1 gene
deletions by real-time PCR. Clin Chem 2009; 55: 1680–1685.
25 Minelli C, Granell R, Newson R, et al. Glutathione-S-transferase genes and asthma phenotypes: a Human Genome
Epidemiology (HuGE) systematic review and meta-analysis including unpublished data. Int J Epidemiol 2010; 39:
539–562.
26 Shaheen SO, Newson RB, Ring SM, et al. Prenatal and infant acetaminophen exposure, antioxidant gene
polymorphisms, and childhood asthma. J Allergy Clin Immunol 2010; 126: 1141–1148.
27 Shaheen SO, Rutterford CM, Lewis SJ, et al. Maternal selenium status in pregnancy, offspring glutathione
peroxidase 4 genotype, and childhood asthma. J Allergy Clin Immunol 2015; 135: 1083–1085.
28 Nurmatov U, Nwaru BI, Devereux G, et al. Confounding and effect modification in studies of diet and childhood
asthma and allergies. Allergy 2012; 67: 1041–1059.
29 Birtchnell J, Evans C, Kennard J. The total score of the Crown-Crisp Experiential Index: a useful and valid
measure of psychoneurotic pathology. Br J Med Psychol 1988; 61: 255–266.
30 Gernand AD, Schulze KJ, Stewart CP, et al. Micronutrient deficiencies in pregnancy worldwide: health effects and
prevention. Nat Rev Endocrinol 2016; 12: 274–289.
31 Jaakkola JJK, Ahmed P, Ieromnimon A, et al. Preterm delivery and asthma: a systematic review and meta-analysis.
J Allergy Clin Immunol 2006; 118: 823–830.
32 Grieger JA, Clifton VL. A review of the impact of dietary intakes in human pregnancy on infant birthweight.
Nutrients 2015; 7: 153–178.
33 Brooks AM, Byrd RS, Weitzman M, et al. Impact of low birth weight on early childhood asthma in the United
States. Arch Pediatr Adolesc Med 2001; 155: 401–406.
34 Tielemans MJ, Erler NS, Leermakers ETM, et al. A priori and a posteriori dietary patterns during pregnancy and
gestational weight gain: the generation R study. Nutrients 2015; 7: 9383–9399.
35 Forno E, Young OM, Kumar R, et al. Maternal obesity in pregnancy, gestational weight gain, and risk of
childhood asthma. Pediatrics 2014; 134: e535–e546.
36 Bédard A, Dumas O, Kauffmann F, et al. Potential confounders in the asthma–diet association: how causal
approach could help? Allergy 2012; 67: 1461–1462.
37 Reynolds CM, Gray C, Li M, et al. Early life nutrition and energy balance disorders in offspring in later life.
Nutrients 2015; 7: 8090–8111.
38 Litonjua AA, Gold DR. Asthma and obesity: common early-life influences in the inception of disease. J Allergy
Clin Immunol 2008; 121: 1075–1084.
39 Maslova E, Rytter D, Bech BH, et al. Maternal protein intake during pregnancy and offspring overweight 20 y
later. Am J Clin Nutr 2014; 100: 1139–1148.
40 Smith GD. Assessing intrauterine influences on offspring health outcomes: can epidemiological studies yield
robust findings? Basic Clin Pharmacol Toxicol 2008; 102: 245–256.
41 Shaheen SO, Newson RB, Smith GD, et al. Prenatal paracetamol exposure and asthma: further evidence against
confounding. Int J Epidemiol 2010; 39: 790–794.
42 Hernán MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004; 15:
615–625.
43 Garcia-Larsen V, Ierodiakonou D, Jarrold K, et al. Diet during pregnancy and infancy and risk of allergic or
autoimmune disease: a systematic review and meta-analysis. PLoS Med 2018; 15: e1002507.
44 Vojnik C, Hurley LS. Abnormal prenatal lung development resulting from maternal zinc deficiency in rats. J Nutr
1977; 107: 862–872.
45 Maret W. Zinc biochemistry: from a single zinc enzyme to a key element of life. Adv Nutr 2013; 4: 82–91.
46 MacDonald RS. Zinc and health: current status and future directions the role of zinc in growth and cell
proliferation. J Nutr 2000; 130: 1500S–1508S.
47 Yarnell JW, Fehily AM, Milbank JE, et al. A short dietary questionnaire for use in an epidemiological survey:
comparison with weighed dietary records. Hum Nutr Appl Nutr 1983; 37: 103–112.
48 Howe LD, Tilling K, Galobardes B, et al. Loss to follow-up in cohort studies. Epidemiology 2013; 24: 1–9.
49 Wessells KR, Brown KH. Estimating the global prevalence of zinc deficiency: results based on zinc availability in
national food supplies and the prevalence of stunting. PLoS One 2012; 7: e50568.
https://doi.org/10.1183/13993003.00507-2018 13
PAEDIATRICS AND ASTHMA | A. BÉDARD ET AL.
